CTX0294885

Pan-kinase inhibitor CAS# 1439934-41-4

CTX0294885

Catalog No. BCC6396----Order now to get a substantial discount!

Product Name & Size Price Stock
CTX0294885: 5mg $127 In Stock
CTX0294885: 10mg Please Inquire In Stock
CTX0294885: 20mg Please Inquire Please Inquire
CTX0294885: 50mg Please Inquire Please Inquire
CTX0294885: 100mg Please Inquire Please Inquire
CTX0294885: 200mg Please Inquire Please Inquire
CTX0294885: 500mg Please Inquire Please Inquire
CTX0294885: 1000mg Please Inquire Please Inquire
Related Products
  • Marimastat

    Catalog No.:BCC2118
    CAS No.:154039-60-8
  • CP 471474

    Catalog No.:BCC2373
    CAS No.:210755-45-6
  • UK 356618

    Catalog No.:BCC2378
    CAS No.:230961-08-7
  • UK 383367

    Catalog No.:BCC2308
    CAS No.:348622-88-8
  • ARP 100

    Catalog No.:BCC2370
    CAS No.:704888-90-4
  • ARP 101

    Catalog No.:BCC2371
    CAS No.:849773-63-3

Quality Control of CTX0294885

Number of papers citing our products

Chemical structure

CTX0294885

3D structure

Chemical Properties of CTX0294885

Cas No. 1439934-41-4 SDF Download SDF
PubChem ID 71558939 Appearance Powder
Formula C22H24ClN7O M.Wt 437.93
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 100 mg/mL (228.35 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-[[5-chloro-2-(4-piperazin-1-ylanilino)pyrimidin-4-yl]amino]-N-methylbenzamide
SMILES CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=CC=C(C=C3)N4CCNCC4
Standard InChIKey FCLOIQHNUARDSR-UHFFFAOYSA-N
Standard InChI InChI=1S/C22H24ClN7O/c1-24-21(31)17-4-2-3-5-19(17)28-20-18(23)14-26-22(29-20)27-15-6-8-16(9-7-15)30-12-10-25-11-13-30/h2-9,14,25H,10-13H2,1H3,(H,24,31)(H2,26,27,28,29)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of CTX0294885

DescriptionCTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against a broad range of kinases in vitro, and further developed it into a Sepharose-supported kinase capture reagent. Target: Kinase capture reagent Use of a quantitative proteomics approach confirmed the selectivity of CTx-0294885-bound beads for kinase enrichment. Large-scale CTx-0294885-based affinity purification followed by LC-MS/MS led to the identification of 235 protein kinases from MDA-MB-231 cells, including all members of the AKT family that had not been previously detected by other broad-spectrum kinase inhibitors. Addition of CTx-0294885 to a mixture of three kinase inhibitors commonly used for kinase-enrichment increased the number of kinase identifications to 261, representing the largest kinome coverage from a single cell line reported to date. Coupling phosphopeptide enrichment with affinity purification using the four inhibitors enabled the identification of 799 high-confidence phosphosites on 183 kinases, ~10% of which were localized to the activation loop, and included previously unreported phosphosites on BMP2K, MELK, HIPK2, and PRKDC. Therefore, CTx-0294885 represents a powerful new reagent for analysis of kinome signaling networks that may facilitate development of targeted therapeutic strategies.

References:
[1]. Zhang L, et al. Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling. J Proteome Res. 2013 Jul 5;12(7):3104-16.

CTX0294885 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

CTX0294885 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of CTX0294885

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.2835 mL 11.4173 mL 22.8347 mL 45.6694 mL 57.0867 mL
5 mM 0.4567 mL 2.2835 mL 4.5669 mL 9.1339 mL 11.4173 mL
10 mM 0.2283 mL 1.1417 mL 2.2835 mL 4.5669 mL 5.7087 mL
50 mM 0.0457 mL 0.2283 mL 0.4567 mL 0.9134 mL 1.1417 mL
100 mM 0.0228 mL 0.1142 mL 0.2283 mL 0.4567 mL 0.5709 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on CTX0294885

CTx-0294885 is a novel bisanilino pyrimidine. It has inhibitory activity towards a wild range of kinases in vitro. CTx-0294885 is capable of capturing more than half of the expressed kinome in MDA-MB-231 cells. Large-scale CTx-0294885-based affinity purification with LC−MS/MS identifies 235 protein kinases. CTx-0294885 binds additional kinases that were not identified from previous studies using other kinase capture reagents. It is further developed into a Sepharose-supported kinase capture reagent. CTx-0294885 is a new tool for analysis of kinome signaling networks. [1]

Reference:
1.  Zhang L, Holmes IP, Hochgräfe F et al. Characterization of the novel broad-spectrum
kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based
kinome profiling.  J Proteome Res. 2013 Jul 5;12(7):3104-16.

Featured Products
New Products
 

Description

CTX-0294885 is a a novel bisanilino pyrimidine; exhibits inhibitory activity against a broad range of kinases in vitro, and further developed it into a Sepharose-supported kinase capture reagent.

Keywords:

CTX0294885,1439934-41-4,Natural Products, buy CTX0294885 , CTX0294885 supplier , purchase CTX0294885 , CTX0294885 cost , CTX0294885 manufacturer , order CTX0294885 , high purity CTX0294885

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: